CHINA BIOTECH SERVICES HOLDINGS LIMITED
Climate Impact & Sustainability Data (2019)
Reporting Period: 2019
Environmental Metrics
Total Carbon Emissions:2,837 tCO2e
Scope 1 Emissions:30 tCO2e
Scope 2 Emissions:467 tCO2e
Scope 3 Emissions:43.7 tCO2e
Total Energy Consumption:681,363 kWh
Water Consumption:1,272 m3
Waste Generated:2.4 tons (non-hazardous) + 1.4 tons (hazardous)
ESG Focus Areas
- Environmental protection
- Social responsibility
- Corporate governance
Environmental Achievements
- Reduced hazardous waste produced from 6.6 tonnes in 2018 to 1.4 tonnes in 2019.
- Promoted a paperless working environment to reduce paper waste.
Social Achievements
- Offered competitive remuneration and benefits schemes to its staff.
- Maintained a high level of occupational safety and health standard, with no work-related injuries or lost days recorded during the reporting period.
- Donated RMB300,000 (approximately HK$329,000) to Nanjing Medical University Education Development Fund.
Governance Achievements
- Established a Remuneration Committee to ensure transparency in determining remuneration packages for directors and senior management.
- Established an Audit Committee to oversee the financial reporting process and internal control systems.
- Established a Nomination Committee to lead the process for appointments to the Board.
Climate Goals & Targets
Environmental Challenges
- Weak consumption sentiments and keen competition in the medical laboratory testing services and health check services industry in Hong Kong.
- Economic downturn in Hong Kong due to China and US trade tensions and social unrest.
- Overall decrease in turnover due to deconsolidation of results from a disposed subsidiary and decreased revenue from laboratory testing and health check services.
Mitigation Strategies
- Adjusting its strategy and continuing to consolidate the market share of its medical testing and healthcare businesses in Hong Kong.
- Focusing on the development and application for registration of immune cell products.
- Strengthening its management team by inviting industry leaders with expertise in medical testing and research.
Supply Chain Management
Supplier Audits: Annual
Responsible Procurement
- Reagents and equipment purchased from ISO accredited vendors.